Image for Cardiovascular Pharmacology Concepts, Richard E Klabunde PhD

Cardiovascular Pharmacology Concepts

Richard E. Klabunde, PhD

Clinical Disorders:

Therapeutic Classes:

Mechanism Classes:

Also Visit

Cardiovascular Physiology Concepts textbook cover

Click here for information on Cardiovascular Physiology Concepts, 2nd edition, a textbook published by Lippincott Williams & Wilkins (2011)


Cardiovascular Physiology Concepts textbook cover

Click here for information on Normal and Abnormal Blood Pressure, a textbook published by Richard E. Klabunde (2013)


Ganglionic Blockers

Autonomic Ganglia

Sympathetic autonomic ganglia are comprised of the paravertebral ganglia (sympathetic chain ganglia) and the prevertebral ganglia

Sympathetic autonomic ganglia are comprised of the paravertebral ganglia (sympathetic chain ganglia) and the prevertebral ganglia. Preganglionic sympathetic fibers that exit the spinal cord synapse within these ganglia and release the neurotransmitter acetylcholine (ACh), which binds to nicotinic receptors. Activation of the nicotinic receptors depolarizes the cell body of the postganglionic neuron and generates action potentials that travel to the target organ to elicit a response.

Parasympathetic autonomic ganglia are found within the target organ. In the case of the vagal nerves that exit the brainstem, their long preganglionic fibers enter the target organ (e.g., heart) where they synapse with postganglionic neurons within small ganglia. Like the sympathetic ganglia, the neurotransmitter is ACh and it binds to nicotinic receptors to activate the short postganglionic fibers that lie near the target tissue (e.g., sinoatrial node).

General Pharmacology

Sympatholytic drugs can block the sympathetic adrenergic system are three different levels. First, peripheral sympatholytic drugs such as alpha receptor antagonists and beta receptor antagonists block the influence of norepinephrine at the effector organ (heart or blood vessel). Second, there are ganglionic blockers that block impulse transmission at the sympathetic ganglia. Third, there are drugs that block sympathetic activity within the brain. These are called centrally acting sympatholytic drugs.

Neurotransmission within the sympathetic and parasympathetic ganglia involves the release of acetylcholine from preganglionic efferent nerves, which binds to nicotinic receptors on the cell bodies of postganglionic efferent nerves. Ganglionic blockers inhibit autonomic activity by interfering with neurotransmission within autonomic ganglia. This reduces sympathetic outflow to the heart thereby decreasing cardiac output by decreasing heart rate and contractility. Reduced sympathetic output to the vasculature decreases sympathetic vascular tone, which causes vasodilation and reduced systemic vascular resistance, which decreases arterial pressure. Parasympathetic outflow is also reduced by ganglionic blockers.

Therapeutic Indications

Ganglionic blockers are not used in the treatment of chronic hypertension in large part because of their side effects and because there are numerous, more effective, and safer antihypertensive drugs that can be used. They are, however, occasionally used for hypertensive emergencies.

Specific Drugs

Several different ganglionic blockers are available for clinical use; however, only one (trimethaphan camsylate) is very occasionally used in hypertensive emergencies or for producing controlled hypotension during surgery.

Side Effects and Contraindications

Side effects of trimethaphan include prolonged neuromuscular blockade and potentiation of neuromuscular blocking agents. It can produce excessive hypotension and impotence due to its sympatholytic effect, and constipation, urinary retention, dry mouth due to it parasympatholytic effect. It also stimulates histamine release.


Revised 03/19/08

DISCLAIMER: These materials are for educational purposes only, and are not a source of medical decision-making advice.